A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2007
11/01/2007	US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007	US20070254866 Aminoquinolones as GSK-3 inhibitors
11/01/2007	US20070254857 2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
11/01/2007	US20070254028 Granules Comprising a Nsaid and a Sugar Alcohol Made by Melt Extrusion
11/01/2007	US20070253962 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto
11/01/2007	US20070253957 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
11/01/2007	CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007	CA2649043A1 Azolecarboxamide derivative
11/01/2007	CA2648578A1 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them
10/2007
10/31/2007	EP1849795A1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
10/31/2007	EP1849479A1 Ameliorating agent for symptoms resulting from joint diseases
10/31/2007	EP1849478A2 Inflammatory mediator antagonists
10/31/2007	EP1849471A1 Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and S-adenosylmethionine
10/31/2007	EP1848442A1 2-methylene-19-nor-(20s-24epi)-1alpha,25-dihydroxyvitamine-d2
10/31/2007	EP1848433A2 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
10/31/2007	EP1848422A2 Method for decreasing cartilage damage in dogs
10/31/2007	EP1848290A2 Compositions and methods for nutrition supplementation
10/31/2007	EP1531807A4 Bazedoxifene treatment regimens
10/31/2007	EP1513821B1 Protein kinase inhibitors
10/31/2007	EP1420801B1 Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/31/2007	EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007	EP1259626B1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
10/31/2007	EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007	EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007	CN200966773Y Osteoproliferation plaster for reducing pain
10/31/2007	CN101065401A Osteoprotegerin variant proteins
10/31/2007	CN101065119A Ameliorant for renal insufficiency
10/31/2007	CN101063161A Coproduction technique for collagen and chondroitin sulfate
10/31/2007	CN101062415A Use of IL-18 inhibitors
10/31/2007	CN101062403A Process for preparing bone peptide injection
10/31/2007	CN101062393A Pill for invigorating blood circulation analgesia
10/31/2007	CN101062383A Exterior-applied prescription for treating cervical vertebrae hyperosteogeny
10/31/2007	CN101062314A Medicine for curing gout and its preparing method
10/31/2007	CN101062297A Branch of cinnamomum wilsonii pill for treating cervical vertebrae
10/31/2007	CN101062295A Medicine for treating neck, lumbar intervertebral disk protrusion and its using method
10/31/2007	CN101062288A Angelica sinensis pill for activating blood circulation and reducing pain
10/31/2007	CN101062257A Medicine for treating totter, crazy and cruel type mental disease
10/31/2007	CN101062235A Chinese traditional medicine agent for treating osteomyelitis
10/31/2007	CN101062233A Powdered medicine for coaptation and its preparing process
10/31/2007	CN101062227A Cyperus tuber pill for activating blood circulation
10/31/2007	CN101062219A Ointment for treating pain
10/31/2007	CN101062217A Medicine combination for treating traumatic injury and the preparing method and the function thereof
10/31/2007	CN101062210A Chinese medicine for treating bone disease
10/31/2007	CN101062200A Angelica fang-feng powder
10/31/2007	CN101062198A Decoction for treating arthritis
10/31/2007	CN101062194A Medicine for treating bone disease and fracture and the preparing method thereof
10/31/2007	CN101062184A Point regulator for treating rheumatism, neuralgia and hyperosteogeny
10/31/2007	CN101062180A Angelica sinensis powder for treating traumatic injury
10/31/2007	CN101062152A Chinese medicine for treating rheumatoid arthritis
10/31/2007	CN101062145A Health drug pillow
10/31/2007	CN101062087A Capsule for treating gout
10/31/2007	CN101062083A Processing method for reducing the poison of triptolide and the corresponding preparation
10/31/2007	CN101062082A Arthralgia treating medical composition
10/31/2007	CN101062023A Selective androgen receptor modulators and methods of use thereof
10/31/2007	CN101062022A Colchicine patch absorbing from skin for treating acute goute arthritis and the preparing method thereof
10/31/2007	CN101062002A Skin-care combination including plant extracts
10/31/2007	CN101061996A Electrolytic water and producing method
10/31/2007	CN101061975A Medicine mat for preventing and treating cervical vertebrae diseases
10/31/2007	CN100345970C Receptor based antagonists and mehtods of making and using
10/31/2007	CN100345863C Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/31/2007	CN100345847C Novel biarylcarboxamides
10/31/2007	CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007	CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007	CN100345576C Medicine composition for treating cervical vertebra, lumbar vertebrae diseases and preparation method thereof
10/31/2007	CN100345571C Medication for treating necrosis of femoral head and preparation method
10/31/2007	CN100345562C Oral liquid for treating cervix severe bone injury
10/31/2007	CN100345549C Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
10/31/2007	CN100345548C Drug for treating fractures
10/31/2007	CN100345545C 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect
10/30/2007	US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007	US7288571 Thyroid receptor ligands and method II
10/30/2007	US7288568 Alzheimer's disease; Parkinson's disease; inflammatory bowel disease; antiarthritic agents
10/30/2007	US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007	US7288541 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
10/30/2007	US7288535 Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates
10/30/2007	US7288534 Sphingomyelin enhancement of tumor therapy
10/30/2007	US7288519 Exocyclic peptide having amino acid sequence of a Fas surface domain; antagonists of the Fas receptor (Fas)-Fas ligand complex
10/30/2007	US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007	CA2509650C C-6 modified indazolylpyrrolotriazines
10/30/2007	CA2264002C Naphthyl compounds, intermediates, compositions, and methods of use
10/30/2007	CA2261564C Parathyroid hormone analogues for the treatment of osteoporosis
10/25/2007	WO2007120702A2 Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto
10/25/2007	WO2007120693A2 Targeted binding agents directed to upar and uses thereof
10/25/2007	WO2007120593A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007	WO2007119973A1 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
10/25/2007	WO2007119887A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ
10/25/2007	WO2007119796A1 Mutant polypeptide having effector function
10/25/2007	WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof
10/25/2007	WO2007119447A1 Therapeutic agent for rheumatoid arthritis
10/25/2007	WO2007118852A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
10/25/2007	WO2003011210A3 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/25/2007	US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007	US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents
10/25/2007	US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007	US20070249663 Corticotropin-Releasing Factor (CRF) receptor antagonist as therapeutic agent for depression, depressive symptom, or irritable bowel syndrome
10/25/2007	US20070249661 Compounds for inflammation and immune-related uses
10/25/2007	US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007	US20070249590 Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders
10/25/2007	US20070249570 Homogeneously formulating microdosed active principles
10/25/2007	US20070249525 Use of erythropoietin in the treatment of rheumatoid arthritis

1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 820